Form 4 for CVS CVS Health
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-03 | 2024-04-01 | CVS | Havanec Laurie P. | EVP, CHRO | F - Tax | $79.56 | -7,630 | 37.6K | -17% | -$607.0K |
| D | 2024-04-03 | 2024-04-01 | CVS | Havanec Laurie P. | EVP, CHRO | A - Grant | $79.56 | +9,426 | 9,426 | New | +$749.9K |
| D | 2024-04-03 | 2024-04-01 | CVS | Havanec Laurie P. | EVP, CHRO | A - Grant | $79.56 | +39.2K | 39.2K | New | +$3.12M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | F | D | 7,630 | $79.56 | 37,553 | D | — | — | |
| 2 | Common | Common Stock (Restricted) | 2024-04-01 | A | A | 9,426 | $79.56 | 9,426 | D | — | — | |
| 3 | Derivative | Stock Option | 2024-04-01 | A | A | 39,184 | $79.56 | 39,184 | D | $79.56 · 2025-04-01 to 2034-04-01 | 39,184 Common Stock |